Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PetMed ExpressPETS +4.35%56 Debt-to-Equity is 0.02 as of Mar. 2026, which is at its 10-year median of 0.02. GuruFocus rates PETS with a GF Score™ of 56/100 and a GF Value™ of $2.88 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 557 Healthcare Providers & Services companies, PetMed Express ranks better than 93.9% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for PetMed Express's Debt-to-Equity or its related term are showing as below:
PETS'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.02 Max: 0.02
Current: 0.02
During the past 13 years, the highest Debt-to-Equity Ratio of PetMed Express was 0.02. The lowest was 0.01. And the median was 0.02.
PETS's Debt-to-Equity is ranked better than 93.9% of 557
companies
in the Healthcare Providers & Services industry
Industry Median: 0.4
vs PETS: 0.02
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
PetMed Express Debt-to-Equity Related Terms
PetMed Express Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for PetMed Express's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PETS vs SHFH, BHIC, SCNX: Debt-to-Equity Comparison
For the Pharmaceutical Retailers subindustry, PetMed Express's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetMed Express Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PetMed Express's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where PetMed Express's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PetMed Express (PETS) has a Debt-to-Equity of 0.02 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on PetMed Express and its competitors. This is near median its historical median of 0.02. Over the past decade, PetMed Express' Debt-to-Equity has ranged from 0.01 to 0.02. According to the industry distribution chart, PetMed Express ranks #34 out of 557 companies in the Healthcare Providers & Services industry, placing it in the top 6.1%.
Is PetMed Express' Debt-to-Equity too high?
PetMed Express' current Debt-to-Equity of 0.02 is near median its 10-year median of 0.02. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 0.02. The Healthcare Providers & Services industry median Debt-to-Equity is 0.40. PetMed Express' value of 0.02 is 95% below this industry median. Based on the distribution chart, PetMed Express ranks #34 out of 557 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, PetMed Express has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PetMed Express' Debt-to-Equity compare to SHFH and BHIC?
According to the Healthcare Providers & Services industry distribution chart, PetMed Express ranks #34 out of 557 companies for Debt-to-Equity. This places PetMed Express in the top 6% of its industry — outperforming the majority of peers. The industry median Debt-to-Equity is 0.40. PetMed Express' value of 0.02 is 95% below this benchmark. Historically, PetMed Express' own Debt-to-Equity has ranged from 0.01 to 0.02 over the past decade. While the company's 10-year median is 0.02 vs. the industry median of 0.40, PetMed Express has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.40, based on 557 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PetMed Express's current Debt-to-Equity of 0.02 is 95% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on PetMed Express and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PetMed Express's current Debt-to-Equity is 0.02, which is near median its own 10-year median of 0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetMed Express stock overvalued right now?
Based on GuruFocus' analysis, PetMed Express (PETS) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.88, compared to a current price of $2.04 — trading 29.2% below its estimated fair value. The current Debt-to-Equity is 0.02, which is near median its 10-year median of 0.02 and 95% below the Healthcare Providers & Services industry median of 0.40. PetMed Express' overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For PetMed Express (PETS), the current Debt-to-Equity is 0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PetMed Express (PETS) Overvalued in 2026?
Based on GuruFocus' analysis, PetMed Express stock appears to be undervalued.
The current stock price of $2.04 is trading 29.2% below its estimated GF Value™ of $2.88.
GuruFocus considers PetMed Express to be Modestly Undervalued.
Key valuation signals for PETS:
Debt-to-Equity: 0.02 (near median its 10-year median of 0.02)
GF Value™: $2.88 vs. price of $2.04 (29.2% below fair value)
Industry Position: 95% below the Healthcare Providers & Services median (#34 of 557)
No single metric tells the full story. See the PETS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
56GF Score
Get the complete analysis for PETS
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PETS has been successfully added to your 
